期刊文献+

去甲异波尔定在大鼠肝微粒体中葡萄糖醛酸化代谢动力学研究 被引量:1

Enzyme Kinetics of Norisoboldine Glucuronidation in Rat Liver Microsomes
原文传递
导出
摘要 目的:研究去甲异波尔定在大鼠肝微粒体中的葡萄糖醛酸化酶促反应动力学。方法:优化去甲异波尔定与大鼠肝微粒体的反应体系,采用超高效液相色谱-质谱联用技术定量检测孵育体系中去甲波尔定代谢产物去甲异波尔定-9-O-α-葡萄糖醛酸苷的浓度,并应用Linewearve-Burk作图分析数据,计算酶促动力学常数。结果:去甲异波尔定-9-O-α-葡萄糖醛酸苷的酶促反应动力学参数Km40.7μmol.L-1,Vmax=909.1 pmol.(min.mg pro)-1,肝清除率CLint(Vmax/Km)=22.3μL.min-1.mg-1。结论:该方法简单、快速、可靠,适应于去甲异波尔定的葡萄糖醛酸化代谢研究;葡萄糖醛酸化是去甲异波尔定代谢的重要途径之一,提示葡萄糖醛酸转移酶的基因多态性及相关性的药物相互作用引起的去甲异波尔定活性和毒性作用的变化值得进一步关注。 Objective: To investigate the enzyme kinetics of norisoboldine glucuronidation in rat liver microsomes. Method: An UPLC-MS method was developed for determination of norisoboldine-9-O-a-glucuronide, a major metabolite of norisoboldine, in liver microsomes incubation system with sinomenine as internal standard. An optimum incubation system was found and the enzyme kinetics parameters of norisoboldine-9-0-a-glucuronide were analyzed and calculated with Linewearve-Burk graphic method. Result: The Km, Vmax and CZint ( Vmax/gm ) of norisoboldine-9-0-a-glucuronide were 40.7 μmol·L^(-1) 909. 1 pmol@(min.mg pro) ^(-1) and 22.3 txL-min^(-1)·mg^(-1) respectively. Conclusion: This method is simple, specific and reliable, which is suitable for the in vitro research of norisoboldine glucuronidation.
出处 《中国实验方剂学杂志》 CAS 北大核心 2012年第21期149-153,共5页 Chinese Journal of Experimental Traditional Medical Formulae
基金 国家重大新药创制专项(2009ZX09103) 国家自然科学基金项目(81102882) 上海市科委中药现代化专项(09dZ1972100)
关键词 去甲异波尔定 去甲异波尔定-9-O-α-葡萄糖醛酸苷 肝微粒体 葡萄糖醛酸化 酶促反应动力学 norisoboldine norisoboldine-9-0-a-glucuronide liver microsomes glucuronidation enzymekinetics
  • 相关文献

参考文献6

  • 1Chou G X, Norio N, Ma C M, et al. Isoquinoline alkaloids from Lindera aggregate [ J ]. Chin J Nat Med, 2005, 3(5) :272.
  • 2Luo Y B, Liu M, Dai Y, et al. Norisoboldine inhibits the production of pro-inflammatory cytokines in lipopoly-saccharide-stimulated RAW 264. 7 cells by down- regulating the activation of MAPKs but not NF-kB [ J ]. Inflammation, 2010, 33 (6) :389.
  • 3Luo Y B, Liu M, Xia Y, et al. Therapeutic effect of norisoboldine, an alkaloid isolated from Radix Linderae, collagen-induced arthritis in mice [ J ]. Phytomedicine, 2010, 17(10) :726.
  • 4Chen J Z, Chou G X, Wang C H, et al. Characterization of new metabolites from in vivo biotransformation of norisoboldine by liquid chromatography/mass spectrometry and NMR spectroscopy [ J ]. J Pharm Biomed Anal, 2010, 52(5) :687.
  • 5Chen J Z, Xu Y, Chou G X, et al. Simultaneous determination of norisoboldine and its major metabolite in rat plasma by ultra-performance liquid chromatography/spectrometry and its application in pharmacokinetic study [ J ]. Biomed Chromatogr, 2011, 25(3) :367.
  • 6陈建忠,侴桂新,王长虹,王峥涛.去甲异波尔定及其代谢产物的药动学与生物利用度研究[J].中国现代应用药学,2012,29(6):473-477. 被引量:6

二级参考文献2

共引文献5

同被引文献6

  • 1侴桂新,中村■夫,马超美,王峥涛,服部征雄.乌药中异喹啉类生物碱(英文)[J].中国天然药物,2005,3(5):272-275. 被引量:16
  • 2Y. Luo,M. Liu,Y. Xia,Y. Dai,G. Chou,Z. Wang.Therapeutic effect of norisoboldine, an alkaloid isolated from Radix Linderae, on collagen-induced arthritis in mice[J].Phytomedicine.2010(10)
  • 3Yubin Luo,Mei Liu,Xiujuan Yao,Yufeng Xia,Yue Dai,Guixin Chou,Zhengtao Wang.Total alkaloids from Radix Linderae prevent the production of inflammatory mediators in lipopolysaccharide-stimulated RAW 264.7 cells by suppressing NF-κB and MAPKs activation[J].Cytokine.2009(1)
  • 4Chan Wang,Yue Dai,Jian Yang,Guixin Chou,Changhong Wang,Zhengtao Wang.Treatment with total alkaloids from Radix Linderae reduces inflammation and joint destruction in type II collagen-induced model for rheumatoid arthritis[J].Journal of Ethnopharmacology.2006(2)
  • 5好桂新,王峥涛,徐珞珊,徐国钧.乌药的化学成分及药理作用[J].中国野生植物资源,1999,18(3):5-10. 被引量:47
  • 6陈建忠,侴桂新,王长虹,王峥涛.去甲异波尔定及其代谢产物的药动学与生物利用度研究[J].中国现代应用药学,2012,29(6):473-477. 被引量:6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部